Breakthrough Preclinical Result in Epilepsy Treatment These findings strengthen our confidence as we progress toward ...
Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions and setting a new standard of care in migraine with REN-based ...
At the forefront of this shift is Nuropod, a U.S.-available, non-invasive, ear-worn vagus nerve stimulation wearable designed to help support reductions in symptoms associated with persistent fatigue, ...
Through Nexalin America, the Company’s division dedicated to U.S. government engagement, the Company participated in advocacy ...
Brain Performance Technologies launches Interventional Psychiatry, expanding access to precision neuromodulation for ...
New appointees to Board and Leadership team bring global strategic, operational and commercial experience from across the medical device sector. New headquarters and state-of-the-art manufacturing ...
Published in the Journal of Clinical Medicine, the study demonstrates that administering treatment of migraine with Remote Electrical Neuromodulation (REN) does not impact blood s ...
As Valentine’s Day gifting trends continue to shift toward wellness-focused products, neuromodulation devices are ...
Magnus Medical sends cease-and-desist letters to protect SAINT, an FDA-cleared breakthrough in accelerated, personalized ...
On 20 February 2026, Orrum Clinical Analytics announced a partnership with LivaNova USA Inc. to link LivaNova’s Essenz Perfusion System with Orrum’s CORE Insights platform, enabling secure, automatic ...
Globus Medical cites successful integration of NuVasive and Nervo and strong domestic spine sales growth as drivers in strong Q4 results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results